natgillin/translations-raw huggingface dataset:
As benzyl alcohol may cross the placenta, it is recommended to use a formulation that does not contain benzyl alcohol.
Benzilalkohol lahko prehaja skozi placento, zato je priporočljivo uporabiti obliko zdravila, ki ne vsebuje benzilalkohola.
Do not start treatment with LOVENOX (and associated names) until 12 hours after the final dose of direct oral anticoagulant.
Zdravljenja z zdravilom LOVENOX (in povezana imena) ne začnite prej kot 12 ur po zadnjem odmerku neposrednega peroralnega antikoagulansa.
Should thrombocytopenia occur, it usually appears between the 5th and the 21st day following the beginning of enoxaparin sodium treatment.
Če se trombocitopenija pojavi, se to po navadi zgodi med 5. in 21. dnem po začetku zdravljenja z natrijevim enoksaparinatom.
• An initial dose of 3,000 IU (30 mg) of LOVENOX (and associated names) will be given as injection into your vein.
• Začetni odmerek 3.000 i.e. (30 mg) zdravila LOVENOX (in povezana imena) boste dobili kot injekcijo v veno.
LOVENOX (and associated names) contains benzyl alcohol and must not be used in newborn and premature neonates (see section 4.3).
Zdravilo LOVENOX (in povezana imena) vsebuje benzilalkohol, zato se ga ne sme uporabljati pri novorojenčkih in nedonošenčkih (glejte poglavje 4.3).
The amount of LOVENOX (and associated names) given to you will depend on your age and the kind of heart attack you have had.
Količina zdravila LOVENOX (in povezana imena), ki jo boste dobili, bo odvisna od vaše starosti in od vrste srčnega infarkta, ki sta jo imeli.
• If you have problems with your kidneys you may be given a smaller amount of LOVENOX (and associated names).
• Če imate težave z ledvicami, boste lahko dobili manjšo količino zdravila LOVENOX (in povezana imena).
In order to assure the accuracy of the small volume to be injected, it is recommended to dilute the drug to 300 IU/mL (3 mg/mL).
Da bi zagotovili točnost majhnih injiciranih količin, je zdravilo priporočljivo razredčiti na 300 i.e./ml
• Rare: Anaphylactic/Anaphylactoid reactions including shock*
• Redki: Anafilaktične/anafilaktoidne reakcije, vključno s šokom* Bolezni živčevja
In surgical patients, haemorrhage complications were considered major: (1) if the haemorrhage caused a significant clinical event, or (2) if accompanied by a haemoglobin decrease ≥ 2 g/dL or transfusion of 2 or more units of blood products.
Pri kirurških bolnikih so bili krvavitveni zapleti ocenjeni kot hudi: (1) če je krvavitev povzročila pomemben kliničen dogodek, ali (2) če jo je spremljalo znižanje hemoglobina za ≥ 2 g/dl ali transfuzija 2 ali več enot krvnih pripravkov.
The administration of medicinal product containing benzyl alcohol as a preservative to neonates has been associated with a fatal “Gasping Syndrome” (see section 4.3).
Uporaba zdravil, ki kot konzervans vsebujejo benzilalkohol, je bila pri novorojenčkih povezana s "sindromom hlastajočega dihanja" s smrtnim izidom (glejte poglavje 4.3).
• If you have restricted mobility due to illness, you will normally be given 4,000 IU (40 mg) of LOVENOX (and associated names) each day.
• Če imate zaradi bolezni omejeno mobilnost, boste po navadi dobili 4.000 i.e. (40 mg) zdravila LOVENOX (in povezana imena) na dan.
The safety and efficacy of LOVENOX (and associated names) has not been evaluated in children or adolescents.
Varnost in učinkovitost zdravila LOVENOX (in povezana imena) pri otrocih in mladostnikih nista bili ocenjeni.
• Haemorrhage As with other anticoagulants, bleeding may occur at any site.
Tako kot pri drugih antikoagulansih se lahko kjer koli v telesu pojavi krvavitev.
• you are going to receive spinal or epidural anesthesia or lumbar puncture (see Operations and Anaesthetics): a delay should be respected between Lovenox use and this procedure.
• če boste prejeli spinalno ali epiduralno anestezijo ali lumbalno punkcijo (glejte Operacije in anestezija): upoštevati je treba zakasnitev med uporabo zdravila Lovenox in tem postopkom.
In case of self-administration, patient should be advised to follow instructions provided in the patient information leaflet included in the pack of this medicine.
V primeru samoinjiciranja je treba bolniku naročiti, naj upošteva navodila v navodilu za uporabo,
• IV (bolus) injection (for acute STEMI indication only):
• Intravensko (bolusno) injiciranje (samo za indikacijo akutni STEMI):
• Stop blood clots forming in the tubes of your dialysis machine (used for people with severe kidney problems).
• Preprečitev nastajanja krvnih strdkov v cevkah dializne naprave (uporablja se pri osebah, ki imajo hude težave z ledvicami).
enoxaparin sodium
natrijev enoksaparinat
For patients have an operation called percutaneous coronary intervention (PCI): Depending on when you were last given LOVENOX (and associated names), your doctor may decide to give an additional dose of LOVENOX (and associated names) before a PCI operation.
Pri bolnikih, ki so jim opravili poseg, imenovan perkutana koronarna intervencija (PKI): Odvisno od tega, kdaj ste nazadnje dobili zdravilo LOVENOX (in povezana imena), se zdravnik lahko odloči za dodaten odmerek zdravila LOVENOX (in povezana imena) pred PKI.
IV (Bolus) Injection (for acute STEMI indication only):
Intravensko (bolusno) injiciranje (samo za indikacijo akutni STEMI):
It must not be used in premature babies or babies up to 1 month old due to the risk risk of severe toxicity including abnormal respiration.
Pri nedonošenčkih in dojenčkih do 1 meseca starosti se ga ne sme uporabljati, ker obstaja tveganje za hude toksične učinke, vključno z nenormalnim dihanjem.
• If you have had a reaction to heparin that caused a severe drop in the number of your clotting cells (platelets) - this reaction is called heparin-induced thrombocytopeniawithin the last 100 days or if you have antibodies against enoxaparin in your blood.
• Če ste imeli v zadnjih 100 dneh reakcijo na heparin, ki je povzročila hudo zmanjšanje števila trombocitov (krvnih ploščic) - takšno reakcijo imenujemo s heparinom izzvana trombocitopenija - ali če imate v krvi protitelesa proti enoksaparinu.
If the combination is indicated, enoxaparin sodium should be used with careful clinical and laboratory monitoring when appropriate.
Če je kombinirano zdravljenje indicirano, je priporočljivo natrijev enoksaparinat uporabljati ob natančnem kliničnem in laboratorijskem nadzoru,
• Because of the content of benzyl alcohol (see section 6.1), enoxaparin sodium multiple dose vial formulation must not be given to newborns or premature neonates (see sections 4.4 and 4.6).
• Zaradi vsebnosti benzilalkohola (glejte poglavje 6.1) se natrijevega enoksaparinata iz večodmernih vial ne sme dajati novorojenčkom ali nedonošenčkom (glejte poglavji 4.4 in 4.6).
Investigations • Rare: Hyperkalaemia* (see sections 4.4 and 4.5)
Preiskave • Redki: Hiperkaliemija* (glejte poglavji 4.4 in 4.5)
• Common: Injection site haematoma, injection site pain, other injection site reaction (such as oedema, haemorrhage, hypersensitivity, inflammation, mass, pain, or reaction)
• Pogosti: Hematom na mestu injiciranja, bolečina na mestu injiciranja, druge reakcije na mestu injiciranja (na primer edem, krvavitev, preobčutljivost, vnetje, masa, bolečina ali reakcija)
LOVENOX (and associated names) works in two ways.
Zdravilo LOVENOX (in povezana imena) deluje na dva načina.
Benzyl alcohol may also cause toxic reactions and anaphylactoid reactions in infants and children up to 3 years old (see section 4.4).
Benzilalkohol lahko pri dojenčkih in otrocih do 3. leta starosti povzroči tudi toksične in anafilaktoidne reakcije (glejte poglavje 4.4).
It is recommended to use the LOVENOX formulation without benzyl alcohol in pregnant women.
Pri nosečnicah je priporočljivo uporabljati obliko zdravila LOVENOX brez benzilalkohola.
If a child accidentally injects or swallows LOVENOX (and associated names), take them to a hospital causualty department straight away.
Če si otrok po nesreči injicira ali zaužije zdravilo LOVENOX (in povezana imena), ga nemudoma peljite v bolnišnično ambulanto za nujno pomoč.
Acetylsalicylic acid is recommended for all patients without contraindications at an initial oral loading dose of 150-300 mg (in acetylsalicylic acid-naive patients) and a maintenance dose of 75325 mg/day long-term regardless of treatment strategy.
Acetilsalicilna kislina je priporočljiva za vse bolnike brez kontraindikacij, in sicer v začetnem peroralnem polnilnem odmerku od 150 do 300 mg (pri bolnikih, ki še niso prejemali acetilsalicilne kisline) in v vzdrževalnem odmerku od 75 do 325 mg/dan dolgoročno, ne glede na strategijo zdravljenja.
- At doses used for prophylaxis
- V odmerkih, ki se uporabljajo za profilakso
If you are going to have a spinal puncture or an operation where an epidural or spinal anaesthetic is used, tell you doctor that you are using LOVENOX (and associated names).
Če imate predvideno spinalno punkcijo ali operacijo, pri kateri se uporablja spinalna ali epiduralna anestezija, morate zdravniku povedati, da uporabljate zdravilo LOVENOX (in povezana imena).
When non-weight adjusted dosing was administered, it was found after a single-SC 4,000 IU (40 mg) dose, that anti-Xa exposure is 52% higher in low-weight women (<45 kg) and 27% higher in lowweight men (<57 kg) when compared to normal weight control subjects (see section 4.4).
Če so uporabili odmerjanje, ki ni bilo korigirano za telesno maso, so po enkratnem subkutanem odmerku 4.000 i.e. (40 mg) ugotovili izpostavljenost anti-Xa, ki je bila pri ženskah z majhno telesno maso (< 45 kg) 52 % večja in pri moških z majhno telesno maso (< 57 kg) 27 % večja kot pri kontrolnih osebah z normalno telesno maso (glejte poglavje 4.4).
If you use more LOVENOX (and associated names) than you should If you think that you have used too much or too little LOVENOX (and associated names), tell your doctor, nurse or pharmacist immediately, even if you have no signs of a problem.
Če ste uporabili večji odmerek zdravila LOVENOX (in povezana imena), kot bi smeli: Če menite, da ste uporabili preveč ali premalo zdravila LOVENOX (in povezana imena), nemudoma obvestite svojega zdravnika, medicinsko sestro ali farmacevta, tudi če nimate nobenih težav.
• If you are allergic to heparin or other low molecular weight heparins such as nadroparin, tinzaparin or dalteparin.
• Če ste alergični na heparin ali druge nizkomolekularne heparine, npr. na nadroparin,
Frequencies are defined as follows: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon
Opredelitev pogostnosti je: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1000 do
Based on literature data the use of enoxaparin sodium 4,000 IU (40 mg) in cirrhotic patients (ChildPugh class B-C) appears to be safe and effective in preventing portal vein thrombosis.
Glede na podatke iz literature je uporaba 4.000 i.e. (40 mg) natrijevega enoksaparinata pri bolnikih s cirozo (Child-Pugh B-C) varna in učinkovita za preprečevanje portalne venske tromboze.
LOVENOX (and associated names) can be used for two different types of heart attack called STEMI (ST segment elevation myocardial infarction) or Non-STEMI (NSTEMI).
Zdravilo LOVENOX (in povezana imena) se lahko uporablja za dve različni vrsti srčnega infarkta: STEMI (srčni infarkt z dvigom spojnice ST) ali ne-STEMI (NSTEMI).
The treatment benefits of enoxaparin sodium, evident for a number of efficacy outcomes, emerged at 48 hours, at which time there was a 35 percent reduction in the relative risk of myocardial reinfarction, as compared with treatment with unfractionated heparin (p<0.001).
Koristi zdravljenja z natrijevim enoksaparinatom, ki so se kazale s številnimi izidi učinkovitosti, so se pojavile po 48 urah: ob tem času je bilo relativno tveganje za ponovni miokardni infarkt 35 odstotkov manjše kot z nefrakcioniranim heparinom (p < 0,001).
• Pregnant women with mechanical prosthetic heart valves The use of enoxaparin sodium for thromboprophylaxis in pregnant women with mechanical prosthetic heart valves has not been adequately studied.
• Nosečnice z mehaničnimi protetičnimi srčnimi zaklopkami Uporaba natrijevega enoksaparinata za tromboprofilakso pri nosečnicah z mehaničnimi protetičnimi srčnimi zaklopkami ni ustrezno raziskana.
What LOVENOX (and associated names) is and what it is used for What you need to know before you use LOVENOX (and associated names) How to use LOVENOX (and associated names) Possible side effects
Kaj je zdravilo LOVENOX (in povezana imena) in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo LOVENOX (in povezana imena) Kako uporabljati zdravilo LOVENOX (in povezana imena)
LOVENOX (and associated names) can be used during breastfeeding.
Zdravilo LOVENOX (in povezana imena) se lahko uporablja med obdobjem dojenja.
This medicinal product is authorised in the Member States of the EEA under the following names: {Name of the Member State} {Name of the medicinal product} {Name of the Member State} {Name of the medicinal product} [See Annex I - To be completed nationally] [For referral procedures, as appropriate] This leaflet was last revised in {MM/YYYY} {month YYYY}.
To zdravilo je odobreno v državah članicah EGP pod naslednjimi imeni: {Ime države članice}{Ime zdravila}
Enoxaparin sodium is a biological substance obtained by alkaline depolymerization of heparin benzyl ester derived from porcine intestinal mucosa.
Natrijev enoksparinat je biološka snov, dobljena z alkalno depolimerizacijo heparinovega benzilestra,
1) Stopping existing blood clots from getting any bigger.
1) Ustavi povečevanje obstoječih krvnih strdkov.
Benzyl alcohol may also cause toxic reactions and anaphylactoid reactions in infants and children up to 3 years old.
Benzilalkohol lahko pri dojenčkih in otrocih do 3. leta starosti povzroči tudi toksične in anafilaktoidne reakcije.
• Extended prophylaxis of DVT following cancer surgery A double-blind, multicenter trial, compared a four-week and a one-week regimen of enoxaparin sodium prophylaxis in terms of safety and efficacy in 332 patients undergoing elective surgery for abdominal or pelvic cancer.
Dvojno slepo multicentrično preskušanje je primerjalo štiritedensko in enotedensko shemo profilakse z natrijevim enoksaparinatom glede varnosti in učinkovitosti pri 332 bolnikih, ki so imeli opravljeno elektivno operacijo zaradi raka v trebuhu ali medeničnem predelu.
• If the patient is a premature or newborn baby up to 1 month because of the risk of severe toxicity including abnormal respiration (“gasping syndrome”).
• Če je bolnik nedonošenček ali novorojenček, mlajši od 1 meseca, ker obstaja tveganje za hude toksične učinke, vključno z nenormalnim dihanjem ("sindrom hlastajočega dihanja").
• Other medicinal products affecting haemostasis such as: - Platelet aggregation inhibitors including acetylsalicylic acid used at antiaggregant dose (cardioprotection), clopidogrel, ticlopidine, and glycoprotein IIb/IIIa antagonists indicated in acute coronary syndrome due to the risk of bleeding, - Dextran 40, - Systemic glucocorticoids.
- zaviralci agregacije trombocitov, vključno z acetilsalicilno kislino v antiagregacijskih odmerkih (zaščita srca), klopidogrel, tiklopidin in antagonisti glikoproteina IIb/IIIa, ki so indicirani pri akutnem koronarnem sindromu, zaradi tveganja za krvavitve, - dekstran 40, - sistemski glukokortikoidi.
No dose reduction is necessary in the elderly patients in haemodialysis indication.
Starejše osebe Starejšim bolnikom odmerka ni treba zmanjšati za hemodializno indikacijo.
LOVENOX (and associated names) 10,000 IU (100 mg)/10 mL is used to stop blood clots forming in the tubes of your dialysis machine (used for people with severe kidney problems).
Zdravilo LOVENOX (in povezana imena) 10.000 i.e. (100 mg)/10 mL se uporablja za preprečitev nastajanja krvnih strdkov v cevkah dializne naprave (uporablja se pri osebah, ki imajo hude težave z ledvicami).
Do not expel the air bubble from the syringe before the injection to avoid the loss of drug when using pre-filled syringes.
V primeru uporabe napolnjene injekcijske brizge iz nje pred injiciranjem ne poskušajte odstraniti zračnega mehurčka, da ne pride do izgube zdravila.
METHOD OF ADMINISTRATION SC / IV
POSTOPEK UPORABE s.c./i.v.
INFORMATION IN BRAILLE LOVENOX 10 x 4,000 IU (10 x 40 mg) Pen
PODATKI V BRAILLOVI PISAVI LOVENOX 10 x 4,000 IU (10 x 40 mg) peresnik
Changing of anticoagulant treatment - Changing from LOVENOX (and associated names) to blood thinners called vitamin-K antagonists (e.g. warfarin)
Menjava antikoagulantnih zdravil - Prehod z zdravila LOVENOX (in povezana imena) na sredstva za redčenje krvi, imenovana antagonisti vitamina K (npr. varfarin)
Besides the anticoagulant effects of enoxaparin sodium, there was no evidence of adverse effects at 15 mg/kg/day in the 13-week SC toxicity studies both in rats and dogs and at 10 mg/kg/day in the 26week SC and IV toxicity studies both in rats, and monkeys.
Poleg antikoagulantnega učinka natrijevega enoksaparinata niso ugotovili znakov neželenih učinkov ne v 13-tedenski študiji toksičnosti subkutane uporabe 15 mg/kg/dan pri podganah in psih ne v 26-tedenskih študiji toksičnosti subkutane in intravenske uporabe 10 mg/kg/dan pri podganah in opicah.
Common (may affect up to 1 in 10 people)
Pogosti (pojavijo se lahko pri do 1 od 10 oseb)
Heparins can suppress adrenal secretion of aldosterone leading to hyperkalaemia (see section 4.8), particularly in patients such as those with diabetes mellitus, chronic renal failure, pre-existing metabolic acidosis, taking medicinal products known to increase potassium (see section 4.5).
Heparini lahko zavrejo izločanje aldosterona iz nadledvičnih žlez in lahko zaradi tega povzročijo hiperkaliemijo (glejte poglavje 4.8), zlasti pri bolnikih s sladkorno boleznijo, kronično odpovedjo ledvic ali obstoječo metabolično acidozo in pri uporabnikih zdravil, ki zvišujejo kalij (glejte poglavje
Your doctor will request you perform blood tests called INR and tell you when to stop LOVENOX (and associated names) accordingly.
Zdravnik vam bo naročil, da opravite preiskavo krvi, imenovano INR, in vam bo glede na to povedal, kdaj naj nehate uporabljati zdravilo LOVENOX (in povezana imena).
- Other thrombolytics (e.g. alteplase, reteplase, streptokinase, tenecteplase, urokinase) and anticoagulants.
- drugi trombolitiki (npr. alteplaza, reteplaza, streptokinaza, tenekteplaza, urokinaza) in antikoagulansi.
LOVENOX (and associated names) contains the active substance called enoxaparin sodium that is a low molecular weight heparin (LMWH).
Zdravilo LOVENOX (in povezana imena) vsebuje zdravilno učinkovino natrijev enoksaparinat, ki je nizkomolekularni heparin (NMH).
Intracranial haemorrhage, Retroperitoneal haemorrhage
Intrakranialna krvavitev, retroperitonealn a krvavitev
For acute STEMI, treatment is to be initiated with a single IV bolus injection immediately followed by a SC injection.
Zdravljenje akutnega STEMI je treba začeti z eno intravensko bolusno injekcijo, ki ji neposredno sledi subkutana injekcija.
Therefore, for patients on enoxaparin sodium, the PCI was to be performed on enoxaparin sodium (no switch) using the regimen established in previous studies i.e. no additional dosing, if last SC administration given less than 8 hours before balloon inflation, IV bolus of 30 IU/ kg (0.3 mg/kg) enoxaparin sodium, if the last SC administration given more than 8 hours before balloon inflation.
Zato je morala biti za bolnike na natrijevem enoksaparinatu PKI narejena na natrijevem enoksaparinatu (brez menjave) in po shemi, oblikovani v predhodnih študijah tj. brez dodatnega odmerjanja, če je bila zadnja subkutana uporaba manj kot 8 ur pred balonskim širjenjem, in intravenski bolus 30 i.e./kg (0,3 mg/kg) natrijevega enoksaparinata, če je bila zadnja subkutana uporaba več kot 8 ur pred balonskim širjenjem.
See “Do not use LOVENOX (and associated names)”.
Glejte tudi "Ne uporabljajte zdravila LOVENOX (in povezana imena)".
Do not inject LOVENOX (and associated names) into a muscle.
Zdravila LOVENOX (in povezana imena) ne injicirajte v mišico.
Excipient(s) with known effect: benzyl alcohol.
Pomožne snovi z znanim učinkom: benzilalkohol.
All Treated DVT Patients with or without PE
Vsi zdravljeni bolniki z GVT, s PE ali brez nje
In these patients, careful clinical monitoring is advised, and biological monitoring by anti-Xa activity measurement might be considered (see sections 4.2 and 5.2).
Pri teh bolnikih je priporočljiv natančen klinični nadzor in v poštev pride biološko spremljanje z meritvijo aktivnosti anti-Xa (glejte poglavji 4.2 in 5.2).
• For acute STEMI, treatment is to be initiated with a single IV bolus injection immediately followed by a SC injection.
• Zdravljenje akutnega STEMI je treba začeti z eno intravensko bolusno injekcijo, ki ji neposredno sledi subkutana injekcija.
For prefilled syringe PL: Instruction for use of the syringe [To be completed locally]
Za navodilo za uporabo napolnjene injekcijske brizge: Navodilo za uporabo injekcijske brizge [Dopolnite lokalno]
Driving and using machines LOVENOX (and associated names) does not affect the ability to drive and operate machinery.
Vpliv na sposobnost upravljanja vozil in strojev Zdravilo LOVENOX (in povezana imena) ne vpliva na sposobnost upravljanja vozil in strojev.
SC injection Do not mix with other products.
6.2 Inkompatibilnosti Subkutano injiciranje Ne mešajte z drugimi zdravili.
(20 mg) or 4,000 IU (40 mg) of LOVENOX (and associated names) each day.
ali 4.000 i.e. (40 mg) zdravila LOVENOX (in povezana imena) na dan.
• LOVENOX (and associated names) is usually given by injection underneath the skin (subcutaneous).
• Zdravilo LOVENOX (in povezana imena) se po navadi injicira pod kožo (subkutano).
After repeated SC 150 IU/kg (1.5 mg/kg) once daily dosing, mean AUC of anti-Xa activity is marginally higher at steady state in obese healthy volunteers (BMI 30-48 kg/m2) compared to nonobese control subjects, while maximum plasma anti-Xa activity level is not increased.
Po večkratni subkutani uporabi 150 i.e./kg (1,5 mg/kg) enkrat na dan je povprečna AUC aktivnosti anti-Xa v stanju dinamičnega ravnovesja pri debelih zdravih prostovoljcih (ITM 30-48 kg/m2) malenkostno večja kot pri nedebelih kontrolnih osebah, največja raven aktivnosti anti-Xa v plazmi pa ni povečana.
• Common: Allergic reaction
Bolezni imunskega sistema • Pogosti: Alergijska reakcija
How to store LOVENOX (and associated names) Contents of the pack and other information
Shranjevanje zdravila LOVENOX (in povezana imena) Vsebina pakiranja in dodatne informacije
• Switch between enoxaparin sodium and direct oral anticoagulants (DOAC) For patients currently receiving enoxaparin sodium, discontinue enoxaparin sodium and start the DOAC 0 to 2 hours before the time that the next scheduled administration of enoxaparin sodium would be due as per DOAC label.
• Prehod med natrijevim enoksaparinatom in neposrednimi peroralnimi antikoagulansi (DOAC - Direct Oral Anticoagulants) Bolnikom, ki trenutno prejemajo natrijev enoksaparinat, slednjega ukinite in uvedite DOAC od 0 do 2
INSTRUCTIONS ON USE [To be completed nationally]
NAVODILA ZA UPORABO: [Izpolni država članica]
Instruction for use of the pen [To be completed locally]
Navodilo za uporabo peresnika [Dopolnite lokalno]
• Your doctor will decide how long you should receive LOVENOX (and associated names).
• Zdravnik bo določil, koliko časa morate prejemati zdravilo LOVENOX (in povezana imena).
The effect of this dose is usually sufficient for a 4-hour session; however, if fibrin rings are found, for example after a longer than normal session, a further dose of 50 IU to 100 IU/kg (0.5 to 1 mg/kg) may be given.
Učinek tega odmerka po navadi zadošča za 4-urno dializo, a če se pojavijo fibrinski obročki, npr. po dializi, ki je daljša kot po navadi, je mogoče dati dodaten odmerek od 50 do
- Systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, and NSAIDs including ketorolac,
Med takšna zdravila spadajo na primer: - sistemski salicilati, acetilsalicilna kislina v protivnetnih odmerkih in NSAID, vključno s ketorolakom,
Enoxaparin sodium may be safely administered with normal saline solution (0.9%) or 5% dextrose in water (see section 4.2).
Natrijev enoksaparinat je mogoče varno dati v fiziološki raztopini (0,9 % raztopina natrijevega klorida) ali 5 % raztopini glukoze v vodi (glejte poglavje 4.2).